We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Further Expands Investigation Into Market Delays of Generics
EC Further Expands Investigation Into Market Delays of Generics
January 14, 2010
A European Commission antitrust investigation into companies allegedly delaying the market entry of generic drugs has expanded again, this time to include
Danish drugmaker H. Lundbeck A/S.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor